SUBSCRIBE
SUBSCRIBE
News   Business   Deals

Orexigen Therapeutics, Inc. Sets IPO at 6 Million Shares, $11-$13 Each

April 10, 2007 | 
1 min read
WASHINGTON, April 9 (Reuters) - Biopharmaceutical company Orexigen Therapeutics on Monday said it is planning an initial public offering of 6 million shares for between $11 and $13 per share.

>>> Discuss This Story

IPO
MORE ON THIS TOPIC
Creative light bulb explodes with colorful paint splashes and shards of glass on a black background. Think differently creative idea concept. Dry paint splatter. Brainstorm and think
Deals
China’s Haisco forms immunology biotech with up to $1.5B from American VCs
August 25, 2026
 · 
1 min read
 · 
Annalee Armstrong
Salary negotiation, pay raise discussion or wages and benefit agreement, business deal or merger and acquisition concept, business people handshake on pile of money banknote after finish agreement.
Obesity
Roche bets up to $2.3B in Hanmi pact for next-gen weight loss drug
August 24, 2026
 · 
2 min read
 · 
Tristan Manalac
Untie the knots - Troubleshooting - problem solving concept image.
Deals
Werewolf and Ambros to tie the knot in $150M rare disease deal
August 21, 2026
 · 
2 min read
 · 
Michael Gibney
Business competitive advantage of paper plane in new competitive, competitor individual pointing in different ways for new competitive advantage on 3D render. Advantage for new idea competition.
IPO
Scribe’s early-stage IPO standout defies biotech’s derisking trend
August 20, 2026
 · 
3 min read
 · 
Gabrielle Masson